Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Acq. announced Asset disposition Employment agrmnt Consulting agrmnt Appointed director
|
Tonix Pharmaceuticals Holding Corp. (TNXP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/04/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
09/29/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
09/29/2023 |
424B4
| Form 424B4 - Prospectus [Rule 424(b)(4)]: |
09/28/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
09/27/2023 |
8-K
| Quarterly results |
08/21/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
08/16/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
08/10/2023 |
8-K
| Quarterly results |
08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/07/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
08/07/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
08/01/2023 |
8-K
| Quarterly results |
07/31/2023 |
8-K
| Quarterly results |
07/28/2023 |
8-K
| Quarterly results |
07/28/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
07/27/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
07/27/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
07/26/2023 |
8-K
| Quarterly results |
07/24/2023 |
8-K
| Quarterly results |
07/18/2023 |
8-K/A
| Quarterly results |
07/17/2023 |
8-K
| Quarterly results |
07/12/2023 |
8-K
| Quarterly results |
07/10/2023 |
8-K
| Quarterly results |
07/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Fin... |
06/16/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
06/07/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data
Docs:
|
"Tonix Pharmaceuticals Announces Data Presentations Involving TNX-1500 for the Prevention of Rejection in Kidney and Heart Allograft Transplantation in Animal Models at the 2023 American Transplant Congress",
"Fc - Modified Anti - CD154 Mab Induced Long Term Renal Allograft Survival without Thromboembolic Complications Ryo Otsuka, Grace Lassiter, Takayuki Hirose, Ahmad Karadagi , Toshihide Tomosugi , Ivy Rosales, Tatsuo Kawai Center for Transplantation Sciences Massachusetts General Hospital, Boston, MA, USA Ryo Otsuka, PhD Research Fellow Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, USA I have no financial relationships with commercial interests to disclose. AND My presentation does not include discussion of off - label or investigational use.",
"Efficacy Of CD154 Blockade With TNX - 1500 To Prevent Heart Allograft Immune Injury I. Ileka 1 , K. Kinoshita 1 , R. Chaban 1 , G. McGrath 1 , Z. Habibabady 1 , C. Miller 1 , J. O 1 , S. Landino 1 , J. Nawalaniec 1 ,S. Fogarty 2 , B. Daugherty 2 , S. Lederman 2 , J. C. Madsen 1 , R. N. Pierson III 1 1 Center for Transplantation Sciences, Massachusetts General Hospital, Boston MA 2 Tonix Pharmaceuticals Inc., Chatham, NJ, USA",
"Tonix Pharmaceuticals Holding Corp. 8-K" |
|
06/01/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
05/31/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/25/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
05/25/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/23/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/17/2023 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits Interactive Data |
05/10/2023 |
4
| BAGGER RICHARD H (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 60,000 options
@ $0.509, valued at
$30.5k
|
|
05/10/2023 |
4
| Bell Margaret Smith (Director) has filed a Form 4 on Tonix Pharmaceuticals Holding Corp.
Txns:
| Granted 60,000 options
@ $0.509, valued at
$30.5k
|
|
|
|
|